These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Considerations on the use in otorhinolaryngology of a new low-dosage sulfonamide: 2-sulfanilamido-5-methylpyrimidine (Archisulfa)]. SCORNAIENGHI G Gazz Med Ital; 1961 Sep; 120():344-6. PubMed ID: 13909895 [No Abstract] [Full Text] [Related]
3. [On ambulatory treatment of infections of the urinary tract with 2-sulfanilamido-5-methylpyrimidine]. HASCHE-KLUENDER R Arztl Forsch; 1962 Feb; 16():I/94-9. PubMed ID: 13905122 [No Abstract] [Full Text] [Related]
4. [On sulfonamide therapy of tonsillitis. Examination of the concentration of the long-action sulfonamide, 2-sulfanilamido-5-methylpyrimidine (Pallidin), in tonsillar tissue]. NESSEL E Med Welt; 1961 Nov; 45():2358-61. PubMed ID: 14479077 [No Abstract] [Full Text] [Related]
5. [Comparative experimental studies on 5-methyl-3-sulfanilamido-isoxazole, other sulfanilamides and antibiotics]. FUST B; BOEHNI E Schweiz Med Wochenschr; 1962 Dec; 92():1599-604. PubMed ID: 13945938 [No Abstract] [Full Text] [Related]
6. [S-Sulfanilamido- and 3-sulfanilamido-1,2,4-thiadiazole]. WOERFFEL U; BEHNISCH R Arch Pharm Ber Dtsch Pharm Ges; 1962 Nov; 295/67():811-6. PubMed ID: 14001457 [No Abstract] [Full Text] [Related]
7. Biologically active nuclear-substituted sulfonamides. I. Chemical and physical properties of some nuclear-substituted sulfanilamido-2-thiazoles and their syntheses. QUAN SF; DANIELS TC; KUMLER WD J Am Pharm Assoc Am Pharm Assoc; 1954 Jun; 43(6 1):321-6. PubMed ID: 13174427 [No Abstract] [Full Text] [Related]
10. [Clinical experiences with the new sulfonamide 5-methyl-3-sulfanilamido-isoxazole]. HOCHULI E Schweiz Med Wochenschr; 1962 Dec; 92():1604-7. PubMed ID: 13963750 [No Abstract] [Full Text] [Related]
11. [THERAPEUTIC ACTION OF 2-SULFANILAMIDO-5-METHOXYPYRIMIDINE ON SUBACUTE AND CHRONIC CHOLECYSTITIS]. VALENTI G; BELLODI G Policlinico Prat; 1964 Aug; 71():1273-7. PubMed ID: 14192188 [No Abstract] [Full Text] [Related]
12. [Influencing of the tubular function in renal excretion of 4-sulfanilamido-2, 6-dimethylpyrimidine]. PORTWICH F; BUTTNER H Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 229(6):513-9. PubMed ID: 13407769 [No Abstract] [Full Text] [Related]
13. [Sulfapyrimidine in chemotherapy; clinical experiences with 6-sulfanilamido-2,4-dimethylpyrimidin, L 30 of Nordmark and Co..]. HAUCH HJ; LUDWIG L; MULHENS K Z Gesamte Inn Med; 1950 Mar; 5(5-6):159-68. PubMed ID: 15425176 [No Abstract] [Full Text] [Related]
14. [PHARMACOKINETICS OF 2-SULFANILAMIDO-5-ETHYLPYRIMIDINE IN MAN]. PLANCHER AC; SALVI G; BACUZZI E Farmaco Prat; 1964 Nov; 19():550-9. PubMed ID: 14234089 [No Abstract] [Full Text] [Related]
16. [Clinical study of a new sulfonamide preparation: Gantrisin by Roche: 3,4-Dimethyl-5-sulfanilamido-isoxazol]. LANGEMANN H Schweiz Med Wochenschr; 1950 Jan; 80(4):78-81. PubMed ID: 15404422 [No Abstract] [Full Text] [Related]